Opendata, web and dolomites
H2020 projects about "alcoholic"
The page lists 36 projects related to the topic "alcoholic".
| # | |||
|---|---|---|---|
| 1 | EPoS | Elucidating Pathways of Steatohepatitis | 2015 |
| 2 | EPIRIN | EPIGENETIC REGULATION OF INFLAMMATION IN NAFLD | 2015 |
| 3 | InCisive | creTRAP for in situ Characterization of Fibrosis-Promoting Pathways in Non-alcoholic Fatty Liver Disease | 2016 |
| 4 | Paediatric LMS | Non-Invasive Quantitative Magnetic Resonance for Obese Children – the Paediatric LiverMultiScan Test | 2015 |
| 5 | GALAXY | GALAXY: Gut-and-liver axis in alcoholic liver fibrosis | 2016 |
| 6 | DeMILI | NON INVASIVE DIAGNOSTIC TEST SERVICE FOR “NON ALCOHOLIC FATTY LIVER DISEASE” MANAGEMENT | 2016 |
| 7 | GCG-T3 Dyslipidemia | Validation and Molecular Characterization of Novel Glucagon-Thyroid Hormone Conjugates for the Efficient Management of Dyslipidemia and Fatty Liver Disease | 2016 |
| 8 | DEMETINL | Decisions in metabolic inflammation of the liver: Adhesive interactions involved in leukocyte retention and resolution of inflammation in metabolic-inflammatory liver disease | 2017 |
| 9 | AVELEDA Fruit Wine | AVELEDA Fruit Wine | 2016 |
| 10 | HepatoMetaboPath | Cellular and molecular mechanisms of metabolic immune activation triggering non-alcoholic steatohepatitis (NASH) and HCC | 2016 |
| 11 | RADIcAL | Non-invasive rapid assessment of chronic liver disease using Magnetic Resonance Imaging with LiverMultiScan | 2016 |
| 12 | TGDNL | Mechanisms of cellular fatty acid homeostasis | 2017 |
| 13 | Foie Gras | Bioenergetic Remodeling in the Pathophysiology and Treatment of Non-Alcoholic Fatty Liver Disease | 2017 |
| 14 | PhasmaFOOD | Portable photonic miniaturised smart system for on-the-spot food quality sensing | 2017 |
| 15 | EXNADMINA | EXercise as a regulator of hepatic NAD metabolism and MItochondrial function in Non-Alcoholic fatty liver disease | 2016 |
| 16 | mtFOIE GRAS | mitoFOIE GRAS: Non-invasive Profiling of Mitochondrial Function in Non-Alcoholic Fatty Liver Disease | 2017 |
| 17 | SULIPRO | A scientifically proven, safe, naturally derived drug for the effective treatment of liver damage - an innovative solution for a significant unmet medical need | 2017 |
| 18 | MEMORIS | Maternal Enteric Microbiota for Offspring's Repertoire development and Illness Susceptibility | 2018 |
| 19 | PRELICAN | Treatment of liver disease and cancer prevention | 2017 |
| 20 | HEPASPHER | Mimicking liver disease and regeneration in vitro for drug development and liver transplantation | 2017 |
| 21 | LITMUS | Liver Investigation: Testing Marker Utility in Steatohepatitis | 2017 |
| 22 | ENGICOIN | Engineered microbial factories for CO2 exploitation in an integrated waste treatment platform | 2018 |
| 23 | OSTtrans | The Role of OSTα/β as a Bile Acid and Drug Transporter in Obesity-Associated Chronic Liver Disease, Nonalcoholic Fatty Liver Disease | 2018 |
| 24 | PhaseControl | How cellular suicide programmes control phase transitions in fatty liver disease and liver cancer | 2018 |
| 25 | 4Sure | Sulphites' substitute in wine; natural and safe | 2018 |
| 26 | BARINAFLD | Using Bariatric Surgery to Discover Weight-Loss Independent Mechanisms Leading to the Reversal of Fatty Liver Disease | 2018 |
| 27 | ArtHep | Hepatocytes-Like Microreactors for Liver Tissue Engineering | 2019 |
| 28 | Food-PPP-NAFLD | Discovery and characterization of food bioactive compounds modulating the Pentose Phosphate Pathway against non-alcoholic fatty liver disease. | 2019 |
| 29 | LIV-AD-ON-CHIP | Unmasking insulin resistance triggering mechanisms using microphysiological two-organ systems as in vitro disease models of metabolic syndrome and non-alcoholic fatty liver disease | 2020 |
| 30 | WineALaCarte | Commercial appliance for an on-demand & custom reduction of alcohol in wine | 2019 |
| 31 | HEPCAN | A Humanized Monoclonal Anti-Claudin1 Antibody (anti-CLDN1 mAb) for Treatment of Hepatocellular Carcinoma (HCC) | 2019 |
| 32 | CYPNASH | Validation of a novel class of cyclophilin inhibitors for the treatment of non-alcoholic steatohepatitis | 2019 |
| 33 | MyeFattyLiver | Unravelling the heterogeneity and functions of hepatic myeloid cells in Non-Alcoholic Fatty Liver Disease | 2019 |
| 34 | EU-PEARL | EU Patient- cEntric clinicAl tRial pLatform | 2019 |
| 35 | LiverScreen | Screening for liver fibrosis - population-based study across European countries | 2020 |
| 36 | MacinNASH | Revealing the contribution of liver macrophage populations to NASH in insulin resistance | 2020 |